Koninklijke Philips (NYSE:PHG) Holdings Decreased by OLD Mission Capital LLC

OLD Mission Capital LLC lessened its stake in Koninklijke Philips (NYSE:PHG) by 62.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 99,797 shares of the technology company’s stock after selling 164,105 shares during the period. OLD Mission Capital LLC’s holdings in Koninklijke Philips were worth $2,527,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the stock. Wilmington Savings Fund Society FSB bought a new position in shares of Koninklijke Philips in the third quarter valued at approximately $54,000. Farther Finance Advisors LLC boosted its stake in Koninklijke Philips by 37.1% during the 4th quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock valued at $54,000 after purchasing an additional 582 shares in the last quarter. Whipplewood Advisors LLC bought a new position in Koninklijke Philips during the 4th quarter valued at $55,000. Millstone Evans Group LLC acquired a new position in shares of Koninklijke Philips during the 4th quarter valued at $60,000. Finally, Allworth Financial LP lifted its holdings in shares of Koninklijke Philips by 24.9% in the fourth quarter. Allworth Financial LP now owns 3,993 shares of the technology company’s stock valued at $105,000 after buying an additional 797 shares during the period. Institutional investors and hedge funds own 13.67% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. StockNews.com raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Saturday, March 8th. Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a report on Tuesday, March 18th. BNP Paribas upgraded Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research report on Tuesday, February 25th. Finally, UBS Group upgraded Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy”.

Koninklijke Philips Stock Performance

Shares of PHG opened at $25.24 on Wednesday. The company has a 50-day moving average of $26.69 and a two-hundred day moving average of $27.47. The stock has a market cap of $23.72 billion, a price-to-earnings ratio of -30.04, a PEG ratio of 0.82 and a beta of 0.78. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.23 and a quick ratio of 0.74. Koninklijke Philips has a one year low of $19.22 and a one year high of $32.91.

Koninklijke Philips (NYSE:PHG) last posted its quarterly earnings data on Wednesday, February 19th. The technology company reported $0.54 EPS for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. The firm had revenue of $5.38 billion during the quarter, compared to analyst estimates of $5.10 billion. On average, equities research analysts expect that Koninklijke Philips will post 1.63 earnings per share for the current year.

Koninklijke Philips Cuts Dividend

The firm also recently declared an annual dividend, which will be paid on Friday, June 6th. Investors of record on Tuesday, May 13th will be given a dividend of $0.886 per share. This represents a yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips’s payout ratio is -89.29%.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.